Login / Signup

Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.

Andrew J ArmstrongRavit GevaHyun Cheol ChungCharlotte LemechWilson H MillerAaron R HansenJong-Seok LeeFrank TsaiBenjamin J SolomonTae Min KimChristian RolfoVincent GirandaYixin RenFang LiuBhargava KandalaTomoko FreshwaterJudy S Wang
Published in: Investigational new drugs (2024)
Keyphrases
  • advanced non small cell lung cancer
  • cell migration
  • epidermal growth factor receptor
  • tyrosine kinase